Myeloproliferative neoplasm primary prevention: Difference between revisions
(Mahshid) |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> | There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> | ||
==Primary Prevention== | ==Primary Prevention== | ||
There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> | There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> Routine monitoring of the [[complete blood count]] on a yearly basis is sufficient for monitoring. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 23:34, 23 June 2018
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm primary prevention On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm primary prevention |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
There is no established method for primary prevention of myeloproliferative neoplasm.[1]
Primary Prevention
There is no established method for primary prevention of myeloproliferative neoplasm.[1] Routine monitoring of the complete blood count on a yearly basis is sufficient for monitoring.
References
- ↑ 1.0 1.1 National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative